ClinicalTrials.Veeva

Menu
J

Janssen Pharmaceuticals | Clinical Pharmacology Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Macitentan
Itraconazole
JNJ-70033093
JNJ-67953964
Lumicitabine
JNJ-64140284
JNJ-64041575
Erdafitinib
JNJ-56136379
JNJ-55308942

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 53 total trials

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

The purpose of this study is to assess the safety, reactogenicity, and immunogenicity of 3 different doses of ExPEC10V and to select the optimal dose...

Active, not recruiting
Extraintestinal Pathogenic Escherichia Coli Prevention
Biological: ExPEC10V
Biological: ExPEC4V

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Actelion Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Johnson & Johnson (J&J) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems